Showing results (121-130 of 268) with videos related to
Sort By:
Pageof 27
Methods and Findings in Experimental and Clinical Pharmacology|August 6, 2005
Gateways to clinical trialsM Bayes, X Rabasseda, J R ProusMethods and Findings in Experimental and Clinical Pharmacology|July 18, 2006
Gateways to clinical trialsM Bayes, X Rabasseda, J R ProusBrain Research. Developmental Brain Research|February 1, 1990
Large unit conductance voltage chloride channels are expressed in mouse neural crest cells and embryonic dorsal root ganglion cellsX Rabasseda, J Valmier, Y Larmet, et al.Drugs of Today (Barcelona, Spain : 1998)|September 5, 2014
Developments in clinical trials: a Pharma Matters reportA Arjona, B Nuskey, X Rabasseda, et al.Neurochemistry International|May 27, 2010
Botulinum neurotoxin inhibits the release of newly synthesized acetylcholine from torpedo electric organ synaptosomesJ Marsal, C Solsona, X Rabasseda, et al.Methods and Findings in Experimental and Clinical Pharmacology|July 3, 2002
Recombinant human endostatin is beneficial to endothelial cell growth exposed to mildly oxidized low-density lipoproteinsB Ren, Y Wang, X Rabasseda, et al.Toxicon : Official Journal of the International Society on Toxinology|January 1, 1990
Tetanus toxin blocks potassium-induced transmitter release and rearrangement of intramembrane particles at pure cholinergic synaptosomesG Egea, X Rabasseda, C Solsona, et al.FEBS Letters|March 23, 1987
ATP release from pure cholinergic synaptosomes is not blocked by tetanus toxinX Rabasseda, C Solsona, J Marsal, et al.Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Botulinum toxin type A blocks the morphological changes induced by chemical stimulation on the presynaptic membrane of Torpedo synaptosomesJ Marsal, G Egea, C Solsona, et al.Neuroscience|January 1, 1989
Increase in reactive cholesterol in the presynaptic membrane of depolarized Torpedo synaptosomes: blockade by botulinum toxin type AG Egea, J Marsal, C Solsona, et al.Pageof 27